The Effectiveness of Anti-miasmatic Management of Bronchial Asthma using Asthma Control Test Assessment criteria – A Prospective Study
试验速览
- 阶段
- Phase 3 4
- 状态
- 招募中
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Analyzing the severity of symptoms in cases diagnosed with Bronchial asthma before medication.
研究概览
简要总结
Various research studies have been conducted previously to evaluate the effectiveness of homoeopathic medicines in the treatment of Bronchial asthma. These studies focused either on witnessing the effectiveness of specific homoeopathic medicines or constitutional medicines in the management of Bronchial asthma. Most of the studies were conducted in the pediatric age group and thus the inclusion of other age groups, in studies related to Bronchial asthma were very less. Results of the previous studies were insignificant as the improvement in the general characteristics of the patient was not assessed. Studies done previously did not address the commonest age group affected and the most common exacerbating factor in cases of Bronchial asthma. In addition to this, the efforts to consider anti–miasmatic medicines in the treatment of Bronchial asthma were not taken. Thus, a prospective study to witness the effectiveness of anti–miasmatic medicines in the treatment of Bronchial asthma using Asthma Control Test (ACT) Assessment Criteria and to identify the commonest age group affected and the triggering factors in cases of Bronchial asthma is planned to fill the existing methodological gap. Thirty cases of Bronchial Asthma fulfilling the inclusion criteria will be purposively selected from the OPD, IPD, Rural Health Centers of Sarada Krishna Homoeopathic Medical College and Hospital. The cases will be subjected to data processing involving miasmatic analysis of symptoms to identify the miasm. A totality will be erected involving the miasm. A suitable homoeopathic anti – miasmatic similimum will be selected accordingly. Selection of potency will be based on the susceptibility of the patients. One dose of the medicine selected will be repeated once in a week based on the improvement of the symptoms. The patient will be asked to administer the medicine orally. The patient will be asked to come for regular follows up one in 2 weeks. Changes observed in the patient will be recorded on subsequent follows-up. Pre and post assessment will be done using the Asthma Control Test (ACT) Assessment Criteria to evaluate the improvement of the patient. The assessment will be done in every follow up using assessment tool.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 6.00 Year(s) 至 80.00 Year(s)(—)
- 性别
- All
入选标准
- •Patient having symptoms of Bronchial Asthma such as dyspnea, expiratory wheeze, cough and tightness of chest.
排除标准
- •Pregnant and Lactating women.
- •Patients with other co-morbidities such as hypertension, diabetes mellitus, dyslipidemia, hyperthyroidism, hypothyroidism, etc.
- •Patients with complications of Bronchial Asthma such as Frequent respiratory infections, Pulmonary collapse, Respiratory failure, Pneumothorax, Cor pulmonale and Allergic bronchopulmonary aspergillosis.
结局指标
主要结局
Analyzing the severity of symptoms in cases diagnosed with Bronchial asthma before medication.
时间窗: 9 MONTHS
次要结局
- Symptomatic and general improvement in the condition of patients through evaluation using assessment tool.(9 MONTHS)
研究者
Dr Tejas Vikas G G
Sarada Krishna Homoeopathic Medical College
